ClearPoint Neuro (CLPT) Short term Debt (2015 - 2020)

ClearPoint Neuro (CLPT) posted Short term Debt of $73985.0 for Q3 2020, down 75.06% sequentially from $296677.0 in Q2 2020.

ClearPoint Neuro (CLPT) Short term Debt (2015 - 2020) Analysis & Trends

ClearPoint Neuro has reported Short term Debt for 5 years, with the latest figure at $73985.0 in Q3 2020.

Quarterly Short term Debt changed N/A year-over-year to $73985.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $73985.0 (changed N/A YoY) and the FY2017 annual result came in at $2.0 million, down 33.33% from the prior year.
Short term Debt declined to $73985.0 in Q3 2020 per CLPT's latest filing, from $296677.0 in the prior quarter.
Over five years, Short term Debt peaked at $3.0 million in Q4 2016 and troughed at $73985.0 in Q3 2020.
A 4-year average of $1.6 million and a median of $2.0 million in 2017 frame the typical range for Short term Debt.
The sharpest annual moves came in 2016 and 2017: Short term Debt slipped 28.99% in 2016, then plunged 33.33% in 2017.
Over 4 years, Short term Debt stood at $3.0 million in 2016, then plunged by 33.33% to $2.0 million in 2017, then changed by 0.0% to $2.0 million in 2018, then slumped by 96.3% to $73985.0 in 2020.
According to Business Quant data, Short term Debt over the past three periods registered $73985.0, $296677.0, and $2.0 million for Q3 2020, Q2 2020, and Q2 2018 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.24 Bn	193.64 Bn	7.27 Bn
2	Stryker	128.63 Bn	125.15 Bn	4.50 Bn
3	Medtronic	119.19 Bn	109.97 Bn	6.41 Bn
4	Boston Scientific	73.51 Bn	72.97 Bn	3.85 Bn
5	Edwards Lifesciences	52.11 Bn	47.85 Bn	1.35 Bn
6	Dexcom	34.64 Bn	32.70 Bn	830.00 Mn
7	GE HealthCare Technologies	34.01 Bn	31.90 Bn	2.18 Bn
8	Koninklijke Philips	26.40 Bn	23.08 Bn	4.55 Bn
9	Steris	23.14 Bn	22.65 Bn	684.20 Mn
10	ClearPoint Neuro	467.73 Mn	438.33 Mn	6.71 Mn

Download Data